TL;DR — The Arthroscopy Association of North America (AANA) 2026 Annual Meeting runs May 14-16, 2026 at the JW Marriott Phoenix Desert Ridge. Roughly 2,000 attendees — almost entirely arthroscopic surgeons and sports medicine specialists — with about 70% holding purchasing authority. That works out to ~1,400 effective buyers and a cost-per-qualified-buyer near $7-$10, which is among the most efficient ratios in orthopedic device marketing. A credible 10x10 lands $30,000-$55,000 all-in including booth build, freight, travel, and a four-person clinical team. Win Phoenix by booking surgeon-level meetings six weeks out, leading with surgical video and peer-reviewed evidence rather than mechanism marketing, and treating mid-May as the front door to the late-spring and summer arthroscopic case-volume cycle for high-volume sports medicine practices.

What AANA Is — and Why Phoenix 2026 Matters

The Arthroscopy Association of North America is the professional home of arthroscopic surgeons — orthopedists who specialize in minimally invasive scope-based procedures on the knee, shoulder, hip, elbow, wrist, and ankle. The AANA Annual Meeting is where this subspecialty congregates each spring. There is no other U.S. meeting where the concentration of arthroscopy decision-makers is this high, this surgical, and this commercially active.

AANA 2026 runs May 14-16, 2026 at the JW Marriott Phoenix Desert Ridge. The resort-based format is an advantage for vendors: foot traffic is dense, hallway conversations are unavoidable, and the compressed three-day schedule forces faster relationship-building than a sprawling convention-center show like AAOS. Phoenix is well connected and the JW Marriott Desert Ridge is a destination property that reliably draws a high attendance share — surgeons who otherwise skip secondary meetings show up for AANA because the venue and the agenda combine clinical density with a credible CME and instructional course track.

The audience is small but extraordinarily concentrated. Roughly 2,000 attendees — about 1,400 of them effective buyers when you adjust for the ~70% with purchasing authority. Layer in a strong fellow and resident presence (sports medicine fellowship faculty are deeply engaged with AANA programming), and you get a floor that is essentially impossible to replicate at any other clinical meeting if your category is arthroscopic. For vendors selling suture anchors, knotless fixation, biologic augmentation, cartilage restoration, hip arthroscopy instruments, shoulder instability constructs, ACL systems, scopes, shavers, RF wands, or fluid management, AANA is the meeting where commercial relationships start.

AANA 2026: The Numbers You Need

The cost-per-attendee math at AANA looks excellent next to broad orthopedic meetings like AAOS. The cost-per-qualified-decision-maker math is even better. A 10x10 at AANA that puts your team in front of 100-150 active arthroscopic surgeons across three days, with eight to twelve scheduled meetings with named target accounts, is typically the most efficient pipeline-generation event of the year for any vendor serving this specialty. The trick is exhibiting like the audience is small, surgical, and high-value — not like the audience is large and shallow.

Pre-Conference Strategy: Build a Surgeon-Level Target List

AANA is small enough that meaningful floor time is almost entirely pre-booked. Surgeons do not wander aimlessly through the exhibit hall — they have specific instructional courses to attend, specific colleagues to find, and specific vendors they have decided to evaluate. If your team plans to "see who shows up," you will leave Phoenix with a stack of badge scans and no pipeline. Pre-show outreach is not optional at AANA.

Build a target surgeon list by mid-March. Start with every high-volume arthroscopic surgeon and sports medicine practice you have ever sold into, then layer in the top 100-150 sports medicine fellowship programs and high-volume hospital-based and ambulatory surgery center sports medicine divisions in your geography. Prioritize fellowship faculty (fellows place adoption seeds that flower three to five years later), high-volume rotator cuff and ACL programs, hip arthroscopy specialists (a small but disproportionately influential cohort), and surgeons known for early adoption of new technology. Aim for a named target list of 80-150 surgeons with the specific clinical and capital decisions each one is making in the next 12 months.

Run a five-touch outreach sequence starting eight weeks out. The cadence that consistently produces pre-booked meetings at specialty meetings: a personalized email referencing a recent publication or fellowship program detail, a LinkedIn connection request from a clinical specialist (not a sales rep), a value-led second email with a peer-reviewed reference or surgical-video link, a third email offering a specific Phoenix meeting slot, and a final pre-show confirmation. Our pre-conference email campaigns guide walks through subject-line patterns, timing, and templates that translate cleanly to AANA.

Leverage AANA-aligned channels. AANA members read a small, well-defined set of journals (Arthroscopy and Arthroscopy, Sports Medicine, and Rehabilitation in particular), follow a small circle of social-media-active fellowship faculty, and pay attention to AANA-sponsored education and online learning. Pre-show advertising and content placement inside that ecosystem reaches the audience at a fraction of the cost of general orthopedic media — and with much higher clinical credibility. If you sell into arthroscopy or sports medicine and you are not advertising inside the AANA ecosystem in the eight weeks before Phoenix, you are leaving meeting yield on the table.

Booth Design and Messaging for Arthroscopic Surgeons

AANA attendees are not a generalist audience. They are subspecialty-trained surgeons who watch arthroscopy video at the speed of habit and can read your data closely. Booth design and messaging that works at a broad orthopedic or general surgical meeting will be politely dismissed at AANA. Win the floor by treating the audience like the procedural experts they are.

Build the booth around three zones. Surgical video zone: looped, high-quality arthroscopic footage of your device in the hands of a credible AANA-aligned surgeon, with case selection, technique nuances, and complication rates honestly displayed. Video is the lingua franca of this specialty — booths without high-quality scope footage signal that you do not understand the audience. Evidence zone: peer-reviewed citations, prospective trial data, and registry outcomes — not glossy marketing claims. Display the journal references and the n-values; surgeons will check. Hands-on zone: where the product category supports it, a hands-on station with sawbones, cadaveric tissue substitutes, or a procedural simulator outperforms any printed material. Arthroscopists assess instruments by feel, and a 90-second hands-on encounter often closes faster than a 30-minute presentation. For implants and biologics, a wet station or model showing fixation behavior under tension is similarly high-converting.

Static graphics should answer the four questions every arthroscopic surgeon asks within 30 seconds of approaching the booth: What is the clinical evidence (and how recent is it)? Which surgeons in my network use this? What is the failure or revision profile? How does this fit into my OR workflow and reimbursement? Generic "improves patient outcomes" claims signal that you do not know the specialty. Specific outcomes data — by procedure, by patient subgroup, with named registries — signals that you do. Our medical conference booth design playbook covers zone layouts and signage hierarchy in more depth, and our AAOS marketing guide covers the broader orthopedic exhibit context.

On-Site Tactics: Instructional Courses, Cadaver Labs, and Surgeon-Level Sales

The vendors who win AANA treat the meeting as a clinical education event with embedded sales activity, not the other way around. Surgeons come for the instructional courses, the cadaver labs, the technique exchange, and the fellowship faculty access. Companies that contribute to that mission — through sponsored instructional courses, hands-on cadaver lab support, journal-quality content, or fellowship-aligned educational programming — earn floor traffic and long-term relationships. Companies that show up with consumer-grade marketing get politely walked past.

Sponsored instructional courses and cadaver labs are the highest-leverage on-site tactics. A well-designed instructional course with two or three respected AANA-aligned faculty, paired with a hands-on cadaver lab in the same content arc, will fill your post-show pipeline more reliably than any other on-site investment. The cost is meaningful — five-figure faculty honoraria, content production, AANA sponsorship and lab fees, plus tissue and lab logistics — but the conversion ratio of attended-course-and-lab to evaluated-product is unusually high in arthroscopy. Surgeons who put their hands on your instrument or fixation construct in a lab setting are dramatically more likely to evaluate it in their own OR within 90 days.

Structure your surgeon-level sales conversations with care. An arthroscopic surgeon evaluating a new suture anchor system, knotless construct, biologic augment, or hip arthroscopy instrument set is making a multi-year preference decision that affects their OR throughput, their reimbursement, and their patient outcomes. They do not want a badge scan and a generic drip. They want a structured 20-30 minute conversation with your clinical specialist (not your sales rep), ideally alongside a peer reference call with a similar-volume arthroscopist already using the product. Block calendar slots in advance for these conversations and protect them aggressively from interruption.

For walk-up leads, use a tiered approach. Tier 1: target-list surgeons and division chiefs you have been pursuing — same-day calendar invites for either an in-Phoenix dinner or a clinical specialist call within five business days. Tier 2: high-volume arthroscopic surgeons not previously on your list — structured nurture sequence with surgical video and clinical content. Tier 3: fellows, residents, PAs, and ATCs — long-cycle nurture aimed at the three-to-five-year horizon when fellows enter independent practice and make first-time preference-item decisions.

Post-AANA Follow-Up: Converting a Late-Spring and Summer Case Cycle

Arthroscopy device deals close on two distinct timelines that often run in parallel. Surgeon preference items — suture anchors, knotless fixation, instrument sets, biologic kits — can convert in 30-90 days once a high-volume arthroscopist decides to switch, particularly when the switch lands ahead of summer ACL and rotator cuff volume. Hospital and ambulatory surgery center capital equipment — arthroscopy towers, scopes, fluid management systems, RF generators, navigation — runs 6-18 months through a value analysis committee and the system's capital budget cycle. Post-AANA follow-up needs to run both clocks in parallel without confusing them.

The most common post-AANA mistake is treating every lead as a single timeline. A high-volume arthroscopist who tells your team they want to evaluate your knotless rotator cuff construct in late-summer needs daily-cadence follow-up in the first two weeks, an in-OR observation visit booked within 30 days, and product on the shelf inside 60 days to capture peak volume. A capital equipment lead from an ASC medical director needs immediate scheduling with the value analysis committee, an economic model tailored to the surgery center's case mix, and a 9-12 month cadence aligned with the budget cycle. Our post-conference follow-up playbook covers the segmentation, CRM workflow, and cadence rules that hold up across both kinds of orthopedic buyers.

Build a fellowship-aware nurture track separately from your surgeon-level pipeline. Today's third-year sports medicine fellow is the surgeon making first-time device-preference decisions in 2028 and 2029. Programs that build relationships with fellows at AANA — sponsored fellowship-focused content, hands-on cadaver lab access, and post-show educational support — compound their AANA investment for years. Most vendors ignore fellows entirely. The ones who do not own the next decade of preference decisions in arthroscopy.

Common Mistakes Vendors Make at AANA

Generic orthopedic messaging. AANA is not AAOS. Booth design, faculty selection, and clinical messaging built for a broad orthopedic audience that includes total joints, spine, trauma, and pediatrics fall flat with arthroscopic surgeons. The clinical specificity required is dramatically higher, and the gap is immediately obvious. If your booth could swap to an AAOS hall without changing a panel, you are under-targeted for AANA.

Underinvesting in surgical video. Arthroscopy is the most video-native subspecialty in orthopedic surgery. Booths without high-quality scope footage looping in HD or 4K, with credible faculty performing the procedure, lose floor traffic in the first hour of day one. If your video assets are weak, address that gap before May rather than papering over it with print.

Skipping cadaver lab and instructional course sponsorship. A booth alone — no matter how premium — produces a fraction of the surgeon-level engagement of a booth paired with a sponsored instructional course or cadaver lab. The vendors who consistently win AANA pipeline integrate booth, course, and lab into a single content arc rather than treating them as separate line items.

Sending the wrong rep mix. AANA rewards clinical specialists, medical affairs presence, and senior arthroscopy-specialist sales reps over generalist territory reps. If your A-team is on a different show that week, your AANA investment will underperform. For a tightly defined specialty meeting, the booth staff is more determinative of outcomes than booth size.

Treating AANA as a one-time investment. Vendors who exhibit at AANA once and disappear earn less than a third of the relationship value of vendors who show up every year and consistently support AANA-aligned education between meetings. Arthroscopy is a relationship specialty, and meaningful pipeline compounds over multi-year presence.

Should You Exhibit at AANA in 2026?

Yes, if you sell into arthroscopy, sports medicine, or any subspecialty that uses scope-based procedures. The categories that consistently see strong AANA ROI include suture anchors and all-suture anchors, knotless fixation systems, ACL and PCL reconstruction systems, meniscal repair devices, cartilage restoration platforms (OATS, ACI-style, particulated cartilage), biologic augmentation (PRP, BMAC, amniotic, adipose), shoulder instability and rotator cuff repair systems, hip arthroscopy instrumentation, small-joint scope systems for elbow, wrist, and ankle, arthroscopy cameras and shavers, RF and ablation wands, fluid management, surgical navigation for sports medicine, and arthroscopy training simulators. Pair AANA with a focused conference marketing ROI framework and the math usually clears with room to spare even for first-time exhibitors — if pre-show meeting booking and post-show follow-up discipline is real.

No, if your audience is total joints, spine, trauma, foot and ankle reconstruction, hand surgery, or pediatrics outside the sports medicine overlap. AAOS and the relevant subspecialty meetings are better fits. AANA is a deep arthroscopic and sports medicine meeting, and the floor traffic will not produce qualified pipeline for products aimed at non-arthroscopic orthopedic buyers.

If you sell into the broader orthopedic device ecosystem, AANA still belongs on your calendar even if it is not your only show. Many AANA-attending arthroscopists also operate on adjacent procedures — distal biceps repair, elbow ligament reconstruction, ankle arthroscopy — and a Phoenix presence pairs well with AAOS for vendors with a sports medicine product line inside a broader orthopedic portfolio. Most arthroscopy-focused medical device companies should treat AANA as a non-negotiable annual investment, not a discretionary one. For broader category context, see our AAOS marketing guide and medical device marketing services.